CD8+ Antigen-Specific T Cells, Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2
Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
CHAIROS Study A Study of MabThera/Rituxan (Rituximab) Maintenance Therapy in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Naive to Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
SCD-Haplo: Phase II Study of HLA-Haploidentical SCT for Aggressive SCD
- Status
- TERMINATED
- Phase
- PHASE2
Study of Danggui Buxue Decoction in Preventing Neutropenia
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
TIL Therapy in Metastatic Melanoma and IL2 Dose Assessment
- Status
- TERMINATED
- Phase
- PHASE2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical Donor
- Status
- COMPLETED
- Phase
- PHASE2
A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Prospective, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (methotrexate, Cyclophosphamide) in Large Granular Lymphocytes Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants With Previously Treated Indolent Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy Study Comparing Velcade Dexamethasone Thalidomide Versus Velcade Cyclophosphamide Dexamethasone as Induction Treatment in the Initial Management of Multiple Myeloma (IFM2013-04)
- Status
- COMPLETED
- Phase
- PHASE3